The medicinal cannabis market is strengthening in Australia, and the country has grand plans of growing, retailing and exporting cannabidiol (CBD) to a keen market.

Among its many applications, CBD is seen as a medicinal aid for people — but what about for pets?

CBD is gaining traction as a remedy for pet ailments as part of an overall treatment plan for chronic illnesses. Read on to learn more about CBD for pets in Australia, from legality to how it can help animals.


What is CBD and is it legal in Australia?

Products containing low doses of CBD are considered safe and legal, provided they have been approved by the Australian Register of Therapeutic Goods (ARTG).

This is a fairly new development — on February 1, 2021, it became legal to purchase low-dose CBD products over the counter at the pharmacist. This change signalled a reclassification of CBD from Australia’s Therapeutic Good Administration; it went from being a Schedule 4 product (prescription medicine) to a Schedule 3 product (pharmacist-only medicine).

The catch is that so far no product has yet been approved by the ARTG — unlike other nations that have differing state laws, or even classify CBD as a dietary supplement, in Australia the classification of CBD as medicine has created a lengthy path for approval. Still, CBD is theoretically a legal substance in Australia.

Because of these circumstances, owners who want to source CBD for their pets will need their vet to prescribe the substance. This can be done providing the product to be used meets four conditions:

  1. Cannabidiol comprises 98 percent or more of the total cannabinoid in the preparation.
  2. Any cannabinoids other than cannabidiol must be only those naturally found in cannabis.
  3. The owner must consent to trial an unlicenced and potentially harmful treatment.
  4. There is adequate monitoring of the furry patient’s response and any side effects.

The process can be tricky, but there are dedicated businesses set up purely to facilitate the process of obtaining legal medicinal CBD for pets — like CBD Vets Australia.

How can CBD help pets?

Through anecdotal data and information, CBD is thought to be able to assist pets with a number of conditions, such as epilepsy, arthritis, stress and anxiety, chronic pain and nausea; it can even help them sleep.

CBD is an antidote for owners looking to soothe their pets’ ailments and keep them both calm and free of pain. As it comes in both capsule and liquid forms, it can be easily mixed in pet food.

In terms of CBD pet products currently available in Australia, animals could access the same CBD oil as humans as of the time of publication.

Importantly, CBD is not to be confused with hemp products. Hemp products, including creams and edible oil, contain extremely low forms of THC cannabis, but are considered to be a safe and legal food product — they are particularly high in omega 3 and six fatty acids.

What’s the outlook for Australia’s CBD pet products market?

It is early days for the CBD pet market in Australia, and more research is needed on the impacts and effects of CBD on our four-legged companions.

There is positive anecdotal feedback on its benefits, but further information is needed to allow a greater number of vets to feel comfortable prescribing CBD to pets.

The industry has seen growth in medicinal cannabis prescriptions in Australia, and it’s possible that the same movement will start to be seen in the pet niche over the coming years, making it a potential avenue for investors to keep an eye on. For now, click the links below for more on Australia’s CBD market:

Don’t forget to follow @INN_Australia for real-time updates!

Securities Disclosure: I, Ronelle Richards, hold no direct investment interest in any company mentioned in this article.

NASDAQ | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documents, after the close of markets that same day.

Keep reading... Show less

Acquisition of solventless cannabis extraction and enhanced delivery technology bolsters the company’s beverage portfolio with valuable IP, adding four innovative brands in the adult-use cannabis market and $17M in assets to the balance sheet

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) announces today that it has entered into a definitive agreement dated September 19, 2021 (the “Agreement”) to acquire Embark Health Inc. (“Embark”).

Keep reading... Show less

Provides additional detail on the strategy to leverage the Phyto brand to drive accelerated growth
The Company expects $5 million in monthly sales by July 2022

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra” or the “Company”), today announced the completion of its previously-announced acquisition of privately held 1204581 B.C. Ltd., doing business as Phyto Extractions (“Phyto Extractions”), the owner of the intellectual property rights for the Phyto Extractions brand. With complete control of the popular Phyto Extractions brand asset, Adastra intends to leverage Phyto Extractions’s proven product development expertise, skilled coast-to-coast sales force, and existing relationships with over 1,400 retail stores across Canada to drive accelerated growth and profitability for an expanded portfolio of Phyto Extractions branded cannabis products. The acquisition is expected to be immediately accretive to Adastra.

Keep reading... Show less

Life Sciences Investor Forum today announced that the presentations from the September 16 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

Keep reading... Show less

Cannabis research firm New Frontier Data has released a new report in which it projects that the value of the total cannabis industry will reach US$51 billion by the year 2025.

Also this week, a few cannabis companies announced new international ventures. This side of the space is full of potential, but is relatively new compared to markets like the US and Canada.

Keep reading... Show less